Tylenol with Codeine: Difference between revisions
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) parser-claude batch MedTemplate pre-fill, mind-medicine combination |
MDElliottMD (talk | contribs) home-claude category backfill (parser-claude gap closure) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 16: | Line 16: | ||
| pregnancy = Limited use; codeine is excreted in breast milk and CYP2D6 ultra-rapid metabolizers can produce fatal neonatal opioid toxicity through breastfeeding (FDA 2017 contraindication in lactation).{{citation needed}} | | pregnancy = Limited use; codeine is excreted in breast milk and CYP2D6 ultra-rapid metabolizers can produce fatal neonatal opioid toxicity through breastfeeding (FDA 2017 contraindication in lactation).{{citation needed}} | ||
| legal = [[USLegal:Schedule III|Schedule III controlled substance]] in US. '''Contraindicated in children <12''' for any indication and in any age post-tonsillectomy/adenoidectomy (FDA 2017 black-box advisory)<ref name="tylenol-codeine-label" /> | | legal = [[USLegal:Schedule III|Schedule III controlled substance]] in US. '''Contraindicated in children <12''' for any indication and in any age post-tonsillectomy/adenoidectomy (FDA 2017 black-box advisory)<ref name="tylenol-codeine-label" /> | ||
| mechanism = <vote slug="codeine-acetaminophen-mech-claim">Codeine is | | mechanism = <vote slug="codeine-acetaminophen-mech-claim">Codeine is itself essentially inactive; its analgesic activity depends on CYP2D6-mediated O-demethylation to morphine (~10% conversion in normal metabolizers). CYP2D6 ultra-rapid metabolizers produce dangerously high morphine levels with risk of fatal respiratory depression, especially in children and infants exposed via breast milk; CYP2D6 poor metabolizers get little analgesic benefit.</vote> The combination with acetaminophen provides additive non-opioid analgesia and lowers required codeine dose. CYP2D6 PGx is one of the most clinically actionable in current pharmacology; CPIC supports genotype-guided opioid selection<ref name="cpic-opioid-cyp2d6">CPIC Guideline for CYP2D6, OPRM1, and COMT and Opioid Use, 2021. https://cpicpgx.org/guidelines/cpic-guideline-for-codeine-and-cyp2d6/</ref>. | ||
}} | }} | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Opioid analgesics]] | |||
[[Category:Non-opioid analgesics]] | |||
[[Category:Schedule III controlled substances]] | |||
[[Category:Fixed-dose combinations]] | |||
Latest revision as of 10:43, 23 May 2026
Opioid analgesic (codeine, weak), Non-opioid analgesic (acetaminophen), Schedule III controlled substance, Fixed-dose combination
Codeine / Acetaminophen
Tylenol with Codeine #3 (30 mg codeine), Tylenol #4 (60 mg codeine), Capital with Codeine, Phenaphen with Codeine
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Common uses
Mild to moderate acute pain0, Postoperative pain (mild)0
Pharmacy
Starting dose
1-2 tablets (15-60 mg codeine, 300-600 mg acetaminophen) PO every 4-6 hours as needed
Preparations
Codeine/acetaminophen 15/300 (#2 historical), 30/300 (#3), 60/300 (#4) mg tablets; 12/120 mg/5 mL elixir
US FDA Max
Acetaminophen 4 g/d absolute; codeine 240-360 mg/d typical practical limit
Pharmacology
Routes
Oral
Onset
30-60 minutes
Duration
4-6 hours
Half-life
Codeine 2.5-3.5 hours; acetaminophen 1-3 hours[2]
Bioavailability
Codeine ~60% (oral); acetaminophen 85-98%[2]
Pregnancy
Limited use; codeine is excreted in breast milk and CYP2D6 ultra-rapid metabolizers can produce fatal neonatal opioid toxicity through breastfeeding (FDA 2017 contraindication in lactation).[citation needed]
Legal status
Schedule III controlled substance in US. Contraindicated in children <12 for any indication and in any age post-tonsillectomy/adenoidectomy (FDA 2017 black-box advisory)[2]
Purported mechanism
Codeine is itself essentially inactive; its analgesic activity depends on CYP2D6-mediated O-demethylation to morphine (~10% conversion in normal metabolizers). CYP2D6 ultra-rapid metabolizers produce dangerously high morphine levels with risk of fatal respiratory depression, especially in children and infants exposed via breast milk; CYP2D6 poor metabolizers get little analgesic benefit.0 The combination with acetaminophen provides additive non-opioid analgesia and lowers required codeine dose. CYP2D6 PGx is one of the most clinically actionable in current pharmacology; CPIC supports genotype-guided opioid selection[1].
References
- ↑ CPIC Guideline for CYP2D6, OPRM1, and COMT and Opioid Use, 2021. https://cpicpgx.org/guidelines/cpic-guideline-for-codeine-and-cyp2d6/
- ↑ 2.0 2.1 2.2 FDA Prescribing Information, Tylenol with Codeine (codeine phosphate / acetaminophen), Janssen, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009898s071lbl.pdf